Covid Vaccine IP: How Big Pharma lobbied against India

Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual......

Vaccines: Look to Russia, not US!

An alert government in Delhi should have begun government-to-government discussions with Moscow the moment it came to know that Russians were developing a vaccine.That is to say, almost an year's......

Timely facilitation of COVID-19 kits will help Sino-India ties: Envoy

India has ordered 15 million personal protection gears besides a few million testing kits from China to fight the coronavirus pandemic in the country and their smooth procurement at stable prices......

2 Indian-Americans win Westinghouse Competition

Two Indian-American high school students are among six individual category winners of the prestigious Siemens Westinghouse Competition National Finals for 2005-06 announced in New York on Monday......

IP environment deteriorating in India: US pharma industry

The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied. "PhRMA remains......

US disapproves Customs seizure of generics

Washington-based Pharmaceutical Research and Manufacturers of America (PhRMA), the representative body of US-based drug firms, has said it does not support the seizure of legitimate generic......

3 Ranbaxy units face ban if US charges are proved

Production at three facilities of Ranbaxy Laboratories could be banned if charges of fraud, forging of documents and manufacturing from unapproved locations, levelled by the US Food and Drug......

India no IPR pariah: US drug lobby report

Amidst threats of Big Pharma relocating its R&D from India due to inadequate intellectual property rights protection, data available with the Pharmaceutical Research and Manufacturers of America,......